NasdaqCM:RAVE
NasdaqCM:RAVEHospitality

US Penny Stocks To Consider In February 2025

As the U.S. stock market faces a challenging period, with major indices like the Dow Jones Industrial Average on track for significant weekly declines, investors are increasingly looking for opportunities that might buck broader trends. The term "penny stocks" may seem outdated, but these smaller or newer companies can still offer intriguing possibilities when they exhibit strong financial health. In this article, we'll explore several penny stocks that stand out due to their financial...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Exploring Three High Growth Tech Stocks in the United States

In the last week, the United States market has been flat, yet it has shown a robust 21% increase over the past year, with earnings expected to grow by 14% annually in the coming years. In this context of overall market growth and stability, identifying high growth tech stocks involves looking for companies with strong innovation potential and solid financial health that can capitalize on these favorable conditions.
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (NYSE:GMED) Reports Strong Sales Growth But Sees US$20 Million Dip In Annual Net Income

Globus Medical (NYSE:GMED) recently reported mixed financial results, with a significant rise in sales to USD 2,519 million but a drop in net income to USD 103 million for the full year ending December 2024. The company's share price exhibited a minor shift of 0.01% in the past week, occurring amidst broader market fluctuations that saw major indexes like the Dow Jones and Nasdaq experience declines due to factors including the UnitedHealth DOJ probe and tech stock performance. While Globus...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Coca-Cola Consolidated (NasdaqGS:COKE) Reports Strong Earnings Growth With US$179 Million Q4 Net Income

Coca-Cola Consolidated (NasdaqGS:COKE) has reported a notable 14.50% price increase over the past quarter. Several factors likely influenced this uptick. The company's robust financial performance, marked by a rise in fourth-quarter sales to $1,747 million and a substantial increase in net income, showcased its strong market position. The completion of a share buyback program, with 42,895 shares repurchased for $51.64 million, likely bolstered investor confidence. Additionally, a declared...